Skip to main content
NCBI home page
Thorax logoLink to Thorax
. 1991 May;46(5):385–390. doi: 10.1136/thx.46.5.385

Cystic fibrosis. 7. Management of cystic fibrosis in different countries. Cystic fibrosis in Copenhagen.

C Koch 1, N Høiby 1
PMCID: PMC1020973  PMID: 2068698

Full text

PDF
385

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Corey M., McLaughlin F. J., Williams M., Levison H. A comparison of survival, growth, and pulmonary function in patients with cystic fibrosis in Boston and Toronto. J Clin Epidemiol. 1988;41(6):583–591. doi: 10.1016/0895-4356(88)90063-7. [DOI] [PubMed] [Google Scholar]
  2. Falk M., Kelstrup M., Andersen J. B., Kinoshita T., Falk P., Støvring S., Gøthgen I. Improving the ketchup bottle method with positive expiratory pressure, PEP, in cystic fibrosis. Eur J Respir Dis. 1984 Aug;65(6):423–432. [PubMed] [Google Scholar]
  3. Finkelstein S. M., Wielinski C. L., Elliott G. R., Warwick W. J., Barbosa J., Wu S. C., Klein D. J. Diabetes mellitus associated with cystic fibrosis. J Pediatr. 1988 Mar;112(3):373–377. doi: 10.1016/s0022-3476(88)80315-9. [DOI] [PubMed] [Google Scholar]
  4. Groth S., Stafanger G., Dirksen H., Andersen J. B., Falk M., Kelstrup M. Positive expiratory pressure (PEP-mask) physiotherapy improves ventilation and reduces volume of trapped gas in cystic fibrosis. Bull Eur Physiopathol Respir. 1985 Jul-Aug;21(4):339–343. [PubMed] [Google Scholar]
  5. Høiby N., Döring G., Schiøtz P. O. Pathogenic mechanisms of chronic Pseudomonas aeruginosa infections in cystic fibrosis patients. Antibiot Chemother (1971) 1987;39:60–76. [PubMed] [Google Scholar]
  6. Høiby N., Pedersen S. S. Estimated risk of cross-infection with Pseudomonas aeruginosa in Danish cystic fibrosis patients. Acta Paediatr Scand. 1989 May;78(3):395–404. doi: 10.1111/j.1651-2227.1989.tb11099.x. [DOI] [PubMed] [Google Scholar]
  7. Jensen T., Pedersen S. S., Garne S., Heilmann C., Høiby N., Koch C. Colistin inhalation therapy in cystic fibrosis patients with chronic Pseudomonas aeruginosa lung infection. J Antimicrob Chemother. 1987 Jun;19(6):831–838. doi: 10.1093/jac/19.6.831. [DOI] [PubMed] [Google Scholar]
  8. Jensen T., Pedersen S. S., Nielsen C. H., Høiby N., Koch C. The efficacy and safety of ciprofloxacin and ofloxacin in chronic Pseudomonas aeruginosa infection in cystic fibrosis. J Antimicrob Chemother. 1987 Oct;20(4):585–594. doi: 10.1093/jac/20.4.585. [DOI] [PubMed] [Google Scholar]
  9. Littlewood J. M., Miller M. G., Ghoneim A. T., Ramsden C. H. Nebulised colomycin for early pseudomonas colonisation in cystic fibrosis. Lancet. 1985 Apr 13;1(8433):865–865. doi: 10.1016/s0140-6736(85)92222-6. [DOI] [PubMed] [Google Scholar]
  10. Pedersen S. S., Jensen T., Høiby N., Koch C., Flensborg E. W. Management of Pseudomonas aeruginosa lung infection in Danish cystic fibrosis patients. Acta Paediatr Scand. 1987 Nov;76(6):955–961. doi: 10.1111/j.1651-2227.1987.tb17271.x. [DOI] [PubMed] [Google Scholar]
  11. Riordan J. R., Rommens J. M., Kerem B., Alon N., Rozmahel R., Grzelczak Z., Zielenski J., Lok S., Plavsic N., Chou J. L. Identification of the cystic fibrosis gene: cloning and characterization of complementary DNA. Science. 1989 Sep 8;245(4922):1066–1073. doi: 10.1126/science.2475911. [DOI] [PubMed] [Google Scholar]
  12. Schønheyder H., Jensen T., Høiby N., Andersen P., Koch C. Frequency of Aspergillus fumigatus isolates and antibodies to aspergillus antigens in cystic fibrosis. Acta Pathol Microbiol Immunol Scand B. 1985 Apr;93(2):105–112. doi: 10.1111/j.1699-0463.1985.tb02860.x. [DOI] [PubMed] [Google Scholar]
  13. Schønheyder H., Jensen T., Høiby N., Koch C. Clinical and serological survey of pulmonary aspergillosis in patients with cystic fibrosis. Int Arch Allergy Appl Immunol. 1988;85(4):472–477. doi: 10.1159/000234554. [DOI] [PubMed] [Google Scholar]
  14. Suter S., Schaad U. B., Roux-Lombard P., Girardin E., Grau G., Dayer J. M. Relation between tumor necrosis factor-alpha and granulocyte elastase-alpha 1-proteinase inhibitor complexes in the plasma of patients with cystic fibrosis. Am Rev Respir Dis. 1989 Dec;140(6):1640–1644. doi: 10.1164/ajrccm/140.6.1640. [DOI] [PubMed] [Google Scholar]
  15. Szaff M., Høiby N. Antibiotic treatment of Staphylococcus aureus infection in cystic fibrosis. Acta Paediatr Scand. 1982 Sep;71(5):821–826. doi: 10.1111/j.1651-2227.1982.tb09526.x. [DOI] [PubMed] [Google Scholar]
  16. Szaff M., Høiby N., Flensborg E. W. Frequent antibiotic therapy improves survival of cystic fibrosis patients with chronic Pseudomonas aeruginosa infection. Acta Paediatr Scand. 1983 Sep;72(5):651–657. doi: 10.1111/j.1651-2227.1983.tb09789.x. [DOI] [PubMed] [Google Scholar]

Articles from Thorax are provided here courtesy of BMJ Publishing Group

RESOURCES